Published in Neuropsychopharmacology on December 01, 1991
Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct (2008) 6.32
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol (2009) 1.99
Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87
Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Mol Psychiatry (2012) 1.16
Serotonin and beyond: therapeutics for major depression. Philos Trans R Soc Lond B Biol Sci (2013) 1.12
G protein-coupled receptors in major psychiatric disorders. Biochim Biophys Acta (2006) 1.12
Putative mechanisms of action of antidepressant drugs in affective and anxiety disorders and pain. J Psychiatry Neurosci (2001) 1.11
The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology (Berl) (2010) 1.08
Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacol Ther (2010) 1.05
Open questions in current models of antidepressant action. Br J Pharmacol (2010) 0.99
Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. Br J Pharmacol (2001) 0.99
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse (2007) 0.95
Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) (2004) 0.94
Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br J Pharmacol (1994) 0.91
Potentiation of the antinociceptive effect of clomipramine by a 5-ht(1A) antagonist in neuropathic pain in rats. Br J Pharmacol (2001) 0.85
Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain. PLoS One (2012) 0.81
Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology (Berl) (2011) 0.80
Corticosteroids regulate 5-HT(1A) but not 5-HT(1B) receptor mRNA in rat hippocampus. Brain Res Mol Brain Res (2000) 0.79
Adaptive changes in the reactivity of 5-HT1A and 5-HT2 receptors induced in rat frontal cortex by repeated imipramine and citalopram. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.79
Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. J Neural Transm (Vienna) (1997) 0.78
Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain. Br J Pharmacol (2003) 0.78
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression. J Psychopharmacol (2013) 0.78
Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectr (2015) 0.78
Sigma receptors [σRs]: biology in normal and diseased states. J Recept Signal Transduct Res (2015) 0.78
Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. Psychopharmacology (Berl) (2015) 0.77
Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study. J Neural Transm (Vienna) (1997) 0.77
Influence of Intensity and Duration of Yoga on Anxiety and Depression Scores Associated with Chronic Illness. Ann Med Health Sci Res (2015) 0.76
Effects of acute tryptophan depletion on raphé functional connectivity in depression. Psychiatry Res (2015) 0.75
Neuropsychopharmacology: Reflections on 40 Volumes. Neuropsychopharmacology (2015) 0.75
Delayed effects of spiperone on serotonin1A receptors in the dorsal hippocampus of rats. J Psychiatry Neurosci (1993) 0.75
Anxiolytic profile of fluoxetine as monitored following repeated administration in animal rat model of chronic mild stress. Saudi Pharm J (2015) 0.75
Current advances and trends in the treatment of depression. Trends Pharmacol Sci (1994) 3.49
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends Neurosci (1996) 2.22
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology (2001) 2.00
Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat. Brain Res (1973) 1.96
Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev (1999) 1.69
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci (1998) 1.56
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci (1998) 1.51
Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse (1987) 1.39
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology (1999) 1.30
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci U S A (2001) 1.30
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J Neurosci (1996) 1.26
The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev (1997) 1.25
Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.22
Treatment resistant depression: methodological overview and operational criteria. Eur Neuropsychopharmacol (1999) 1.18
Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol (1987) 1.17
Processing of the papain precursor. The ionization state of a conserved amino acid motif within the Pro region participates in the regulation of intramolecular processing. J Biol Chem (1995) 1.15
A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry (1990) 1.12
Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci (1983) 1.10
Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology (2008) 1.09
Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science (1978) 1.07
Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry (2001) 1.06
Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers. Br J Pharmacol (1999) 1.06
Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther (2001) 1.05
Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. Br J Pharmacol (1997) 1.03
Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology (1996) 1.01
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology (2000) 0.99
Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.99
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system. Arch Gen Psychiatry (1983) 0.99
Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci (1994) 0.99
Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones. Nature (1984) 0.98
Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res (2001) 0.98
In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther (1992) 0.97
Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology (Berl) (2001) 0.97
Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci (2001) 0.97
Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study. Psychopharmacology (Berl) (1999) 0.96
In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci (1986) 0.96
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin. Br J Pharmacol (1994) 0.95
The monomeric guanosine triphosphatase rab4 controls an essential step on the pathway of receptor-mediated antigen processing in B cells. J Exp Med (1998) 0.94
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission. Neuropharmacology (1991) 0.94
Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors. J Endocrinol (1996) 0.93
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain. Eur Neuropsychopharmacol (2000) 0.93
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response. Neuropsychopharmacology (1997) 0.93
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. Eur J Pharmacol (1998) 0.93
Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry (1998) 0.92
Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology (1996) 0.92
Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology (1998) 0.92
Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int Clin Psychopharmacol (1995) 0.91
Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropharmacology (1984) 0.90
In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.90
Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology (1994) 0.89
Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther (1984) 0.89
Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. J Pharmacol Exp Ther (1991) 0.89
Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.89
Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology (1995) 0.89
Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus. Synapse (2001) 0.89
In vivo electrophysiological examination of 5-HT2 responses in 5-HT2C receptor mutant mice. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.88
Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther (1988) 0.88
In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex. Neuropharmacology (1997) 0.88
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience (1985) 0.88
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor. J Pharmacol Exp Ther (1992) 0.88
Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther (1986) 0.88
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine. Brain Res (1988) 0.87
Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology (Berl) (1984) 0.87
Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology (1995) 0.87
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse (1999) 0.87
Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments. Neuropsychopharmacology (2000) 0.86
Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain. J Pharmacol Exp Ther (1996) 0.86
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission. J Affect Disord (1998) 0.86
Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors. Am J Psychiatry (1994) 0.86
Acute tyrosine depletion and alcohol ingestion in healthy women. Alcohol Clin Exp Res (2000) 0.86